Image of seesaw with a lightbulb on the left and money on the right to show LifeArc launches £10m COVID-19 clinical research fund

LifeArc launches £10m COVID-19 clinical research fund

LifeArc, a UK-based medical research charity, has created a £10m COVID-19 clinical research fund to support research to accelerate the development and testing of...
Image of lab equipment to show Synairgen to start trial of SNG001 in COVID-19

Synairgen to start trial of SNG001 in COVID-19

Respiratory drug discovery and development company Synairgen has received expedited approvals from the Medicines and Healthcare products Regulatory Agency (MHRA) and Health Research Authority...
Image of a microscope and papers to show Study of siltuximab for treating COVID-19 serious respiratory complications initiated

Study of siltuximab for treating COVID-19 serious respiratory complications initiated

A study of siltuximab for treating COVID-19 serious respiratory complications has been initiated. EUSA Pharma has announced the initiation of the Papa Giovanni XXIII Hospital...
Image of a scientist at their lab to show Study shows existing anti-parasitic drug kills coronavirus within 48 hours

First coronavirus vaccine clinical trial starts

The first coronavirus vaccine clinical trial has started at Kaiser Permanente Washington Health Research Institute (KPWHRI) in Seattle. The Phase 1 clinical trial is...
Image of a hand with germs on it to show Roche COVID-19 test gets emergency FDA authorisation

FDA emergency authorisation for Roche’s COVID-19 test

Roche has announced that the U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for its COVID-19 test, the cobas®...
Image of scientists standing around a giant magnifying glass with books, charts and research to show Elsevier gives full access to its coronavirus information centre content

Elsevier gives full access to its coronavirus information centre content

Elsevier is giving full access to its content on its coronavirus information centre for PubMed Central and other public health databases, such as the...
Image of raised blocks with lots of research and scientific items on to show Free scientific advice for coronavirus medicine or vaccine developers

Free scientific advice for coronavirus medicine or vaccine developers

The European Medicines Agency is offering free scientific advice to coronavirus medicine or vaccine developers. EMA is providing full fee waivers for scientific advice applications from...
Image of Pf Awards 2020 logo to indicate pf awards 2020 coronavirus update

Pf Awards 2020 coronavirus update 

It is with deepest regret that we have taken the decision to cancel the Pf Awards 2020. Please see our updated statement. With the Pf...
Image of six test tubes containing different coloured liquids to show Clover and GSK collaborate on coronavirus vaccine candidate

Clover and GSK collaborate on coronavirus vaccine candidate

Clover Biopharmaceuticals, a China based global clinical-stage biotechnology company focused on developing novel and transformative biologic therapies, announced that it has entered into a...

Latest articles

Government launches call for evidence to improve women's health and care

Government launches call for evidence to improve women’s health and care

The government is launching a 12-week call for evidence to better understand women’s experiences of the health and care system. Launching to coincide with International...
COVID-19 one year on - key changes

COVID-19 and key changes one year on

One year on from the first confirmed case of COVID-19 in the UK, Oli Hudson, Content Director at Wilmington Healthcare, takes a look at...
FDA approval for Roche’s Actemra/RoActemra in lung disease

FDA approves Roche’s Actemra/RoActemra for interstitial lung disease

Roche has announced that the U.S. Food and Drug Administration (FDA) has approved Actemra®/RoActemra® (tocilizumab) subcutaneous injection for slowing the rate of decline in...

Popular articles

Image of a person descending a ladder over coronavirus to show New Normal, New Thinking: Life Post COVID-19

New Normal, New Thinking: Life Post COVID-19

New thinking will be required to adapt to the new normal life post COVID-19. I hate to start this article on a negative note, but...
Image of a scientist at their lab to show Study shows existing anti-parasitic drug kills coronavirus within 48 hours

Study shows anti-parasitic drug ivermectin kills coronavirus within 48 hours

A collaborative study led by the Monash Biomedicine Discovery Institute (BDI) with the Peter Doherty Institute of Infection and Immunity (Doherty Institute), a joint...
Nasal spray to protect against COVID-19 is ready for use in humans

Nasal spray to protect against COVID-19 is ready for use in humans

A nasal spray to provide protection against the COVID-19 virus has been formulated by researchers at the University of Birmingham, UK, using compounds already...

Pharma marketing: UK vs US

    Marketing medicines is a totally different ball game on each side of the pond. The US is the only country, apart from New Zealand, which...
Roche test aids clinicians in accelerating tuberculosis diagnosis and treatment

The role of women in the NHS in England

This International Women’s Day, NHS Digital has published an analysis of the role of women in the NHS in England. Women account for more than...

Subscribe

Sign up to receive your free UK subscription to Pf Magazine and our digital newsletters, for all the essential headlines, Jobs of the Week, and thought-provoking features.

Claim my free subscription